Institutional Research Information Service
UCL Logo
Please report any queries concerning the funding data grouped in the sections named "Externally Awarded" or "Internally Disbursed" (shown on the profile page) to your Research Finance Administrator. Your can find your Research Finance Administrator at https://www.ucl.ac.uk/finance/research/rs-contacts.php by entering your department
Please report any queries concerning the student data shown on the profile page to:

Email: portico-services@ucl.ac.uk

Help Desk: http://www.ucl.ac.uk/ras/portico/helpdesk
Publication Detail
Immunoregulatory potential of T2-MZP B cells
  • Publication Type:
    Journal article
  • Publication Sub Type:
  • Authors:
    Blair PA, Ehrenstein MR, Mauri C
  • Publication date:
  • Pagination:
    79, 84
  • Journal:
    Future Rheumatology
  • Volume:
  • Issue:
  • Status:
  • Print ISSN:
B cells with the capacity to inhibit inflammatory immune responses have now been described in a number of experimental models of autoimmunity, infection and cancer. Just as the identification of regulatory T cells offers a possible target for the control of aberrant immune responses, a well-defined regulatory B-cell subset may have the potential to be manipulated in vivo for the treatment of conditions such as rheumatoid arthritis, multiple sclerosis, systemic lupus erythematosus and inflammatory bowel disease. In this review, we discuss the latest findings showing that immature transitional-2 (T2-MZP) B cells can produce IL-10 and are able to prevent or ameliorate collagen-induced arthritis. These results ascribe T2-MZP B cells with a previously unrecognized regulatory capacity. © 2008 Future Medicine Ltd.
Publication data is maintained in RPS. Visit https://rps.ucl.ac.uk
 More search options
UCL Researchers
Div of Infection & Immunity
Div of Infection & Immunity
University College London - Gower Street - London - WC1E 6BT Tel:+44 (0)20 7679 2000

© UCL 1999–2011

Search by